{
    "title": "New data sets stage for broader use of AstraZeneca breast cancer drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10886527/New-data-sets-stage-broader-use-AstraZeneca-breast-cancer-drug.html",
    "date": "2022-06-05",
    "keywords": [
        "cancer",
        "breast",
        "chemotherapy",
        "enhertu",
        "treatment",
        "disease",
        "survival",
        "approval",
        "drug",
        "group",
        "lung",
        "grover",
        "oncology",
        "population",
        "trial",
        "her2low",
        "analysis",
        "benefit",
        "progression",
        "pfs",
        "astrazeneca",
        "month",
        "london",
        "june",
        "form",
        "sunday",
        "data",
        "society",
        "asco",
        "meeting",
        "chicago",
        "patient",
        "thirdline",
        "phase",
        "round",
        "median",
        "point",
        "fredrickson",
        "executive",
        "vice",
        "president",
        "unit",
        "lot",
        "confidence",
        "host",
        "prognosis",
        "half",
        "her2",
        "status",
        "average",
        "measure",
        "peak",
        "infusion",
        "safety",
        "type",
        "versus",
        "class",
        "release",
        "cellkilling",
        "secondline",
        "option",
        "study",
        "risk",
        "death",
        "kadcyla",
        "use",
        "kind",
        "paradigm",
        "tara",
        "consultant",
        "pharma",
        "custom",
        "intelligence",
        "sankyo",
        "compound",
        "deal",
        "reporting",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}